Over and under-regulation in the Colorado Cannabis industry - A data-analytic perspective

Lessons learned in several states eight years after states legalized marijuana

There are over 20 000 peer-reviewed research articles linking marijuana use to severe mental health outcomes, ranging from depression to psychosis, and inhibited cognitive development, as well as consequences for physical health, and even negative outcomes for neonates exposed in utero. The connections between marijuana use and consequences to mental and physical health, and brain development, among other risks are often lost in conversations on legalization. Marijuana-legal states have higher rates of marijuana-related driving fatalities, greater emergency room visits, hospitalizations, and exposures, expansive criminal markets, as well as exacerbated racial disparities in industry participation and criminal justice enforcement. We compiled eight years' worth of publicly available state-level data, reports, investigatory findings, peer-reviewed studies, and government health surveys to assemble this 'lessons learned' report to bring these harms to light.

Plant-Based Modulators of Endocannabinoid Signaling

Extracts from Cannabis species have aided the discovery of the endocannabinoid signaling system (ECSS) and phytocannabinoids that possess broad therapeutic potential. Whereas the reinforcing effects of C. sativa are largely attributed to CB1 receptor agonism by Δ⁹-tetrahydrocannabinol (Δ⁹-THC), the observed medicinal effects of Cannabis arise from the combined actions of various compounds. In addition to compounds bearing a classical cannabinoid structure, naturally occurring fatty acid amides and esters resembling anandamide and 2-arachidonoyl glycerol isolated from non- Cannabis species are also valuable tools for studying ECSS function. This review highlights the potential of plant-based secondary metabolites from Cannabis and unrelated species as ECSS modulators.